Navigation Links
Regeneron Named World's #1 Biopharmaceutical Employer in Science Magazine Annual Survey
Date:9/21/2012

Nita Lowey and other public officials are scheduled to participate in an event with Regeneron's Tarrytown employees that will recognize this important achievement.

Separately, Regeneron announced another step to reinforce its commitment to science by launching a new Post-Doctoral Training Program that is accepting applications for its 2013 class.  The three-year multi-faceted program will integrate cutting edge science with didactic training, discussion groups, and focused mentoring.

About Regeneron Pharmaceuticals, Inc.  
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use; ZALTRAP is co-commercialized with Sanofi.  Regeneron has filed a regulatory application with the U.S. Food and Drug Administration (FDA) for a second indication for EYLEA.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.

Contact Information:   
Peter Dworkin   
Corporate Communications  
914.847.7640  
peter.dworkin@regeneron.com

Manisha Narasimhan, Ph.D.  
Investor Relations    
914.847.5126   &#
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron Announces September 2012 Investor Conference Presentations
2. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
3. Regeneron Announces June 2012 Investor Conference Presentations
4. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
5. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
6. Mersana Therapeutics Named a "Fierce 15" Biotech Company for 2012
7. Donor Alliance Named Colorados Top Healthcare Company
8. Millennium Laboratories Angela Huskey Named Industry Pain Educator of the Year by American Society of Pain Educators
9. Impact Advisors Named to Inc. 5000 List of Nations Fastest-Growing Companies
10. Ingenuity Systems Named 2013 World Economic Forum Technology Pioneer
11. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), ... , will present at the Jefferies 2015 Global Healthcare Conference ... ET on Monday, June 1, 2015. The ... "live" listen only Webcast. To listen, please go to: ... available for those unable to listen live. ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015  Eli ... final results of the Phase III PROCLAIM trial ... presentation at the American Society of Clinical Oncology ... . PROCLAIM was a randomized, Phase III superiority ... lung cancer (NSCLC), which evaluated Lilly,s ALIMTA ® ...
(Date:5/28/2015)... , May 28, 2015  Based on its ... & Sullivan recognizes Lexmark Healthcare with ... for Company of the Year in Healthcare Content ... to the next level of interoperability and cost ... followed them up with large-scale product development and ...
Breaking Medicine Technology:PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 2PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 4PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 5PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 6PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 7PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 8Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5
... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
... April 5, 2007-- Stent thrombosis,restenosis and lifelong prescriptions. ... used as part of their heart,operations may be ... than medical experts have ever publicly acknowledged. Recent,articles ... drug-eluting stents continue to take blood thinners, they,could ...
Cached Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
(Date:5/28/2015)... 28, 2015 AMVETS leaders this week ... winner Robert Davis of Newark, Del. AMVETS National Commander ... on winning the $10,000 sweepstakes grand prize. , AMVETS ... entries from around the country for prizes ranging from ... place on May 21 at the AMVETS National Headquarters ...
(Date:5/28/2015)... 2015 The Paw Project, ... dramatic billboard intended to educate the Oregon public about ... busy intersection of Market Street and Park Avenue in ... You’re for De-clawing Cats, Raise Your Hand,” depicts a ... joint, providing a graphic and anatomically-correct representation of the ...
(Date:5/28/2015)... House, PA (PRWEB) May 28, 2015 ... Dalglish, today announced a just launched blog series which ... cultures. Hosted on the “R. Bruce Dalglish” profile ... decades of R. Bruce Dalglish’s corporate experience. , ... that positive workplace cultures have upon the overall success ...
(Date:5/28/2015)... TX (PRWEB) May 28, 2015 Ticket Down ... friendly soccer match between Mexico and Argentina in ... in the world will compete on the pitch at AT&T ... one another in an international friendly on Tuesday, September 8th ... most talented nations in the world including some of the ...
(Date:5/28/2015)... Real Time Pain Relief (RTPR), makers of the ... best-selling lotion is now available in a convenient new four ... registered OTC pain relief product. It contains a proprietary blend ... Arnica, Capsicum, Chondroitin, Emu Oil, Glucosamine, Menthol and MSM. The ... – to avoid buildup of Substance P in joints and ...
Breaking Medicine News(10 mins):Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 3Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2
... DURHAM, N.C. -- A combination of two drugs shows promise ... originates in the eye and spreads to other organs, according ... Center researchers. , The drugs -- decitabine, which can ... an immune system protein -- may work together to cause ...
... laboratory of Dr. David R. Soll at the University ... field of cancer research, thanks to a new agreement ... part of the National Institutes of Health. , The ... for Cancer ( http://proteomics.cancer.gov ) recently selected the Developmental ...
... N.Y. (Tues., Sept. 4, 2007) Skin cancer is ... States, according to the Centers for Disease Control. But ... scientists must use model organisms, such as mice, to study ... Cold Spring Harbor Protocols ( www.cshprotocols.org ) includes ...
... in heart muscle, researchers say , , TUESDAY, Sept. 4 ... treatment in women who have angina, the piercing chest ... with heart disease, has been given fast-track status by ... will enroll about 300 women at 50 medical centers ...
... for stroke patients whove lose part of their vision? ... & Neural Repair explores that question. , The researchers ... the training would induce specific changes in the brains ... never in humans with brain injury. The home-based therapy ...
... 4 EaglePicher Corporation,(EaglePicher) today announced that it ... Boron, LLC (EP Boron) to,Ceradyne, Inc. (Nasdaq: ... Oklahoma, has produced enriched boron,isotopes and products containing ... materials industries. Its products include,isotope B11, an additive ...
Cached Medicine News:Health News:Promising drug combination may help those with ocular melanoma that has spread 2Health News:Laboratory at UI plays major role in diagnosing cancer 2Health News:Laboratory at UI plays major role in diagnosing cancer 3Health News:A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols 2Health News:Trial to Test Gene Therapy for Angina in Women 2Health News:Trial to Test Gene Therapy for Angina in Women 3Health News:EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million 2
...
... Storage in bottom of tray ... etc. Anodized aluminum. Durable and ... rust. Security locks ensure against ... bumper guards hold instruments in ...
Lance shaped gently curved tip. Flat serrated handle with polished finish....
For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model....
Medicine Products: